Article
miR-455-3p in peripheral blood is a potentially superior diagnostic marker for prostate cancer to PSA
2023-11-17
Abstract excerpt
<h4>Purpose: </h4> Prostate-specific antigen (PSA) is commonly used as a biomarker to diagnose and predict the course of prostate cancer (PCa). However, PSA detection is susceptible to changes in the physiologic environment, which may lead to some misdiagnosis. Thus, it is crucial to find a novel diagnostic marker. Methods GEO2R platform was used to screen for a target miRNA in two GEO datasets (GSE206793 and GSE...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 59025da1-1b39-543c-8db8-9a57b5615723
- DOI
- 10.21203/rs.3.rs-3609286/v1
